Invesco Ltd.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
14,357
Total Value
320244803394
Accession Number
0000914208-25-000230
Form Type
13F-HR
CIK
0000914208
Manager Name
Invesco Ltd.
Data Enrichment
96% identified
13,831 identified526 unidentified

Holdings

14,357 positions
Manager:
SEC
Search and click to pin securities to the top
Page 184 of 188
Caribou Biosciences, Inc.
CRBU|142038108
Shares:
58974(-10.2%)
Value:
$53.8M(-48.4%)
AbCellera Biologics Inc.
ABCL|00288U106
Shares:
24146(+114.6%)
Value:
$53.8M(+63.3%)
i-80 Gold Corp.
IAUX|44955L106
Shares:
92274(-0.9%)
Value:
$53.7M(+18.8%)
Liberty Latin America Ltd.
LILA|G9001E102
Shares:
8376(-93.7%)
Value:
$53.0M(-93.7%)
Rimini Street, Inc.
RMNI|76674Q107
Shares:
15049(-3.1%)
Value:
$52.4M(+26.2%)
CADIZ INC
CDZI|127537207
Shares:
17794(-3.4%)
Value:
$52.1M(-45.6%)
Regulus Therapeutics Inc.
RGLS|75915K309
Shares:
29460(-2.6%)
Value:
$51.6M(+7.9%)
RISKIFIED LTD.
RSKD|M8216R109
Shares:
10994
Value:
$50.8M
Autolus Therapeutics plc
AUTL|05280R100
Shares:
32738(+53.3%)
Value:
$50.7M(+1.1%)
Phathom Pharmaceuticals, Inc.
PHAT|71722W107
Shares:
8055(+1.0%)
Value:
$50.5M(-22.0%)
ModivCare Inc
MODV|60783X104
Shares:
38104(-20.0%)
Value:
$50.1M(-91.1%)
FrontView REIT, Inc.
FVR|35922N100
Shares:
3853
Value:
$49.3M
Personalis, Inc.
PSNL|71535D106
Shares:
13869(-2.3%)
Value:
$48.7M(-40.6%)
Perspective Therapeutics, Inc.
CATX|46489V302
Shares:
22742(+27.8%)
Value:
$48.4M(-14.7%)
SERA PROGNOSTICS, INC.
SERA|81749D107
Shares:
13124(-4.3%)
Value:
$48.3M(-56.7%)
Dakota Gold Corp.
DC|46655E100
Shares:
18150(+1.3%)
Value:
$48.1M(+22.0%)
Gossamer Bio, Inc.
GOSS|38341P102
Shares:
43697
Value:
$48.1M
Aveanna Healthcare Holdings, Inc.
AVAH|05356F105
Shares:
8704(-3.7%)
Value:
$47.2M(+14.2%)
ALX ONCOLOGY HOLDINGS INC
ALXO|00166B105
Shares:
73836
Value:
$46.0M
Stereotaxis, Inc.
STXS|85916J409
Shares:
26025(-3.6%)
Value:
$45.8M(-25.6%)